ALZAMEND Trademark

Trademark Overview


On Wednesday, June 29, 2022, a trademark application was filed for ALZAMEND with the United States Patent and Trademark Office. The USPTO has given the ALZAMEND trademark a serial number of 97977427. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by Alzamend Neuro, Inc.. The ALZAMEND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical, biologic and immunological research and development; pharmaceutical, biologic and immunological product development; pharmaceutical, biologic and immunological drug and vaccine development services
alzamend

General Information


Serial Number97977427
Word MarkALZAMEND
Filing DateWednesday, June 29, 2022
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7327469
Registration DateTuesday, March 12, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements


Goods and ServicesPharmaceutical, biologic and immunological research and development; pharmaceutical, biologic and immunological product development; pharmaceutical, biologic and immunological drug and vaccine development services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 19, 2022
Primary Code042
First Use Anywhere DateMonday, November 8, 2021
First Use In Commerce DateMonday, November 8, 2021

Trademark Owner History


Party NameAlzamend Neuro, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326

Party NameAlzamend Neuro, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326

Party NameAlzamend Neuro, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326

Trademark Events


Event DateEvent Description
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 12, 2024REGISTERED-PRINCIPAL REGISTER
Monday, February 5, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, January 25, 2024NOTICE OF ALLOWANCE CANCELLED
Monday, February 5, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, January 25, 2024DIVISIONAL REQUEST RECEIVED
Friday, January 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 25, 2024TEAS REQUEST TO DIVIDE RECEIVED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU EXTENSION 1 GRANTED
Thursday, January 11, 2024SOU EXTENSION 1 FILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023ASSIGNED TO EXAMINER
Tuesday, July 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 2, 2022NEW APPLICATION ENTERED